Prof. Dr. med. Bodo-Eckehard Strauer did his first clinical treatment using adult stem cell transplant for a heart patient on March 30, 2001, over ten years ago. Since that time, he and his team have treated hundreds of patients, have published a text on such heart treatments, and many other groups around the world have used adult stem cells for treatment of heart disease.
Scientists at the University of Wisconsin-Madison have used detailed, high-tech analysis to examine the differences between human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC).
Scientists have shown for the first time that cultured red blood cells can be grown in the lab from adult stem cells and injected successfully into a human. While embryonic stem cells produce only unsuitable, immature cells, with rejection and uncontrolled tumor growth remaining a concern as well, by contrast adult stem cells can efficiently produce healthy, safe cells for transfusion.
Canadian scientists have published data that indicate exercise stimulates adult stem cells to form bone instead of fat.
Adult stem cells are safe as well as feasible for treatment of stroke in patients, according to the published results of a ground-breaking Phase I trial from the University of Texas Health Science Center at Houston.
Stress can stimulate production of new adult neural stem cells. An area of the brain known as the hippocampus responds to environmental conditions, including stress such as being held in isolation, and produces new neural stem cells that are stockpiled for later use.
Like an out of control youth, embryonic stem cells can wreak havoc with tissue damage and tumor formation. Their inability to make appropriate, mature cells that can function in an adult body is also a problem.